pubmed-article:16778130 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16778130 | lifeskim:mentions | umls-concept:C0007226 | lld:lifeskim |
pubmed-article:16778130 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:16778130 | lifeskim:mentions | umls-concept:C0534519 | lld:lifeskim |
pubmed-article:16778130 | lifeskim:mentions | umls-concept:C1705786 | lld:lifeskim |
pubmed-article:16778130 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:16778130 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:16778130 | lifeskim:mentions | umls-concept:C0018591 | lld:lifeskim |
pubmed-article:16778130 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:16778130 | pubmed:dateCreated | 2006-7-7 | lld:pubmed |
pubmed-article:16778130 | pubmed:abstractText | Caspase-1 processes the interleukin (IL)-1beta and IL-18 inactive precursors to the biologically active cytokines that are known to have proatherogenic effects. The present study investigated the genetic variability of the CASP1 gene and plasma levels of caspase-1 in relation to cardiovascular risk. In Europeans, 3 tag SNPs captured 4 common haplotypes of the CASP1 gene. Among these, the A(in6) allele of the G+7/in6A polymorphism was less frequent in 246 cases with myocardial infarction and a parental history of disease than in 253 controls free of familial history of disease (0.13+/-0.02 versus 0.20+/-0.02; P=0.005). However, in a larger case/control study (n=1774), these effects are borderline restricted to the UK population. In a prospective cohort of 1168 patients with coronary artery disease followed up during a median period of 6.0 years, the A(in6) allele exhibited a borderline association with future cardiovascular death (hazard ratio [HR]: 0.64, 0.41 to 1.01; P=0.053) and was associated with lower serum IL-18 levels (P=0.014). Baseline caspase-1 levels in the top quartile of the distribution were predictive of cardiovascular deaths (HR=3.62, 1.81 to 7.27; P=0.0003 compared with the bottom quartile). Finally, in vitro assays of allelic imbalance showed that the CASP1 haplotype carrying the A(in6) allele was associated with a lower mRNA expression. These results indicate that caspase-1 levels are predictive of future cardiovascular death in patients with coronary artery disease. The role of CASP1 genetic variations in the susceptibility to myocardial infarction requires further investigation. | lld:pubmed |
pubmed-article:16778130 | pubmed:language | eng | lld:pubmed |
pubmed-article:16778130 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16778130 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16778130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16778130 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16778130 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16778130 | pubmed:month | Jul | lld:pubmed |
pubmed-article:16778130 | pubmed:issn | 1524-4571 | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:RupprechtHans... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:BlankenbergSt... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:BickelChristo... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:AtheroGene... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:CambienFranço... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:NicaudViviane... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:TiretLaurence... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:EvansAlunA | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:KeeFrankF | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:MorrisonCarol... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:PoirierOdette... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:BarbauxSandri... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:MünzelThomasT | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:LacknerKarl... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:SchnabelRenat... | lld:pubmed |
pubmed-article:16778130 | pubmed:author | pubmed-author:GodefroyTipha... | lld:pubmed |
pubmed-article:16778130 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:16778130 | pubmed:day | 7 | lld:pubmed |
pubmed-article:16778130 | pubmed:volume | 99 | lld:pubmed |
pubmed-article:16778130 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16778130 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16778130 | pubmed:pagination | 102-8 | lld:pubmed |
pubmed-article:16778130 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:meshHeading | pubmed-meshheading:16778130... | lld:pubmed |
pubmed-article:16778130 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16778130 | pubmed:articleTitle | Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk. | lld:pubmed |
pubmed-article:16778130 | pubmed:affiliation | Department of Medicine II, Johannes Gutenberg-University Mainz, Mainz, Germany. blankenberg@2-med.klinik.uni-mainz.de | lld:pubmed |
pubmed-article:16778130 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16778130 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:834 | entrezgene:pubmed | pubmed-article:16778130 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:16778130 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16778130 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16778130 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16778130 | lld:pubmed |